United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$23Mraised across 1 round since 2019, from 1 source
Venrock
RA Capital Management
RTW Investments LLC
Boxer CapitalReported by Globenewswire
From the SEC filings it signed: 2 on the team.
On the board, as filediAdam TomasiRoderick Wong
Missing a round, or an investor who was in one? Tell us.
Attune Pharmaceuticals's investors include Venrock Healthcare Partners/ LifeSci Venture, Venrock, RA Capital Management, RTW Investments LLC and Boxer Capital, and 1 more on record. Venrock Healthcare Partners/ LifeSci Venture led its latest round.
Attune Pharmaceuticals has raised $23M across 1 round since 2019.
Attune Pharmaceuticals's most recent round was a Series B of $23M in Jan 2019, led by Venrock Healthcare Partners/ LifeSci Venture.
Its most recent round, $23M in Jan 2019, is also its largest on record.
Attune Pharmaceuticals's first round on record, in Jan 2019, was backed by Venrock Healthcare Partners/ LifeSci Venture, Venrock and RA Capital Management and 3 others.
Attune Pharmaceuticals's latest named round is a Series B, in Jan 2019.
Attune Pharmaceuticals is based in the United States.
Venrock Healthcare Partners/ LifeSci Venture led the Series B in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
